PriceTargets.com logo

Plexus - PLXS Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $125.25
  • Forecasted Upside: -7.92%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$136.02 As of 10/4/2024 01:00 AM ET
▲ +1.53 (1.14%)

This chart shows the closing price for PLXS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Plexus Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PLXS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PLXS

Analyst Price Target is $125.25
▼ -7.92% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Plexus in the last 3 months. The average price target is $125.25, with a high forecast of $150.00 and a low forecast of $95.00. The average price target represents a -7.92% upside from the last price of $136.02.

This chart shows the closing price for PLXS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 4 polled investment analysts is to moderate buy stock in Plexus. This rating has held steady since January 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
4/15/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
7/14/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
10/12/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
1/10/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/9/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
7/8/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
10/6/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/1/2024BenchmarkBoost TargetBuy ➝ Buy$145.00 ➝ $150.00
7/29/2024BenchmarkBoost TargetBuy ➝ Buy$120.00 ➝ $145.00
7/26/2024Needham & Company LLCBoost TargetBuy ➝ Buy$114.00 ➝ $144.00
6/21/2024BenchmarkBoost TargetBuy ➝ Buy$110.00 ➝ $120.00
4/26/2024Stifel NicolausBoost TargetHold ➝ Hold$90.00 ➝ $95.00
4/26/2024Needham & Company LLCBoost TargetBuy ➝ Buy$107.00 ➝ $114.00
1/25/2024Needham & Company LLCLower TargetBuy ➝ Buy$110.00 ➝ $107.00
1/18/2024Needham & Company LLCLower TargetBuy ➝ Buy$113.00 ➝ $110.00
1/17/2024BenchmarkReiterated RatingBuy ➝ Buy$110.00
1/9/2024SidotiDowngradeBuy ➝ Neutral$112.00
10/27/2023Needham & Company LLCBoost TargetBuy ➝ Buy$107.00 ➝ $113.00
7/28/2023Needham & Company LLCBoost TargetBuy$105.00 ➝ $107.00
1/27/2023SidotiUpgradeNeutral ➝ Buy$116.00
1/27/2023JPMorgan Chase & Co.Lower TargetUnderweight$90.00 ➝ $86.00
1/27/2023Needham & Company LLCLower TargetBuy$112.00 ➝ $108.00
1/17/2023SidotiDowngradeBuy ➝ Neutral$116.00
11/1/2022BenchmarkBoost Target$110.00
10/28/2022Raymond JamesBoost TargetOutperform$105.00 ➝ $115.00
10/28/2022Needham & Company LLCBoost TargetBuy$105.00 ➝ $112.00
8/29/2022BenchmarkBoost TargetBuy$101.00 ➝ $105.00
8/12/2022JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$85.00
7/27/2022BenchmarkInitiated CoverageBuy$98.00
6/7/2022Raymond JamesUpgradeMarket Perform ➝ Outperform$100.00
1/28/2022Needham & Company LLCLower TargetBuy$95.00 ➝ $90.00
1/19/2022Needham & Company LLCLower TargetBuy$105.00 ➝ $95.00
10/29/2021Needham & Company LLCLower TargetBuy$108.00 ➝ $105.00
9/10/2021Needham & Company LLCReiterated RatingBuy$108.00
8/23/2021Fox-Davies CapitalUpgradeEqual Weight ➝ Overweight$110.00
7/19/2021Raymond JamesSet TargetHold$85.73
6/22/2021SidotiUpgradeNeutral ➝ Buy$110.00
6/11/2021Loop CapitalBoost TargetBuy$100.00 ➝ $105.00
5/25/2021Needham & Company LLCBoost TargetBuy$102.00 ➝ $110.00
4/26/2021Loop CapitalBoost TargetBuy$91.00 ➝ $100.00
4/23/2021Needham & Company LLCBoost TargetPositive ➝ Buy$89.00 ➝ $102.00
3/31/2021SidotiDowngradeBuy ➝ Neutral$94.00
1/28/2021SidotiUpgradeNeutral ➝ Buy
1/22/2021Needham & Company LLCBoost TargetBuy$77.00 ➝ $89.00
1/19/2021SidotiDowngradeBuy ➝ Neutral$89.00
8/12/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$78.00
7/24/2020Stifel NicolausBoost TargetHold$60.00 ➝ $80.00
7/24/2020Loop CapitalBoost TargetPositive ➝ Buy$78.00 ➝ $91.00
7/24/2020Needham & Company LLCBoost TargetBuy$67.00 ➝ $82.00
6/8/2020Loop CapitalBoost TargetBuy$70.00 ➝ $78.00
4/20/2020Loop CapitalInitiated CoverageBuy$70.00
4/15/2020JPMorgan Chase & Co.Boost TargetOverweight$67.00 ➝ $72.00
3/24/2020Needham & Company LLCLower TargetBuy$80.00 ➝ $67.00
3/11/2020SidotiUpgradeNeutral ➝ Buy$83.00
3/9/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$84.00
2/27/2020Raymond JamesInitiated CoverageMarket Perform
1/24/2020SidotiBoost TargetNeutral$72.00 ➝ $83.00
1/24/2020Needham & Company LLCBoost TargetBuy$80.00 ➝ $88.00
10/25/2019SidotiDowngradeBuy ➝ Neutral
(Data available from 10/6/2019 forward)

News Sentiment Rating

0.81 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 9 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/10/2024
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/9/2024
  • 14 very positive mentions
  • 13 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2024
  • 22 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2024
  • 6 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2024
  • 15 very positive mentions
  • 14 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2024
  • 12 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2024
  • 11 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
10/6/2024

Current Sentiment

  • 11 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Plexus logo
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors. The company was founded in 1979 and is headquartered in Neenah, Wisconsin.
Read More

Today's Range

Now: $136.02
Low: $134.99
High: $136.94

50 Day Range

MA: $125.93
Low: $114.81
High: $136.71

52 Week Range

Now: $136.02
Low: $87.21
High: $138.20

Volume

94,273 shs

Average Volume

128,183 shs

Market Capitalization

$3.73 billion

P/E Ratio

37.57

Dividend Yield

N/A

Beta

0.89

Frequently Asked Questions

What sell-side analysts currently cover shares of Plexus?

The following equities research analysts have issued research reports on Plexus in the last year: Benchmark Co., Needham & Company LLC, Sidoti, Stifel Nicolaus, and TheStreet.
View the latest analyst ratings for PLXS.

What is the current price target for Plexus?

4 Wall Street analysts have set twelve-month price targets for Plexus in the last year. Their average twelve-month price target is $125.25, suggesting a possible downside of 7.9%. Benchmark Co. has the highest price target set, predicting PLXS will reach $150.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $95.00 for Plexus in the next year.
View the latest price targets for PLXS.

What is the current consensus analyst rating for Plexus?

Plexus currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for PLXS.

What other companies compete with Plexus?

Other companies that are similar to Plexus include SMTC, Jabil, Fabrinet, Sanmina and IPG Photonics. Learn More about companies similar to Plexus.

How do I contact Plexus' investor relations team?

Plexus' physical mailing address is One Plexus Way, Neenah WI, 54957. The technology company's listed phone number is (920) 969-6000 and its investor relations email address is [email protected]. The official website for Plexus is www.plexus.com. Learn More about contacing Plexus investor relations.